Repro Med Systems (KRMD) Tops Q3 EPS by 2c, raises guidance

Repro Med Systems (NASDAQ: KRMD) reported Q3 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $10.4 million versus the consensus estimate of $9.66 million.

GUIDANCE:

Repro Med Systems sees FY2025 revenue of $40.5-41 million, versus the consensus of $39.94 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• L3Harris CEO steps down amid conduct review, shares drop